2025-08-14 |
13G/A
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
7,877,349 |
9,474,397 |
|
|
|
2025-08-14 |
13G/A
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
7,877,349 |
0 |
|
|
|
2025-08-14 |
13G
|
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
|
|
|
55,368,760 |
|
|
|
2025-08-14 |
13G/A
|
VSTM / Verastem, Inc.
|
|
4,245,476 |
5,626,803 |
|
|
|
2025-08-14 |
13G/A
|
QURE / uniQure N.V.
|
|
4,265,428 |
5,158,231 |
|
|
|
2025-08-14 |
13G/A
|
TSHA / Taysha Gene Therapies, Inc.
|
|
20,673,307 |
25,183,287 |
|
|
|
2025-08-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
3,152,341 |
3,424,180 |
|
|
|
2025-08-14 |
13G/A
|
XGN / Exagen Inc.
|
|
1,504,602 |
1,696,866 |
|
|
|
2025-08-14 |
13G/A
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
7,877,349 |
9,474,397 |
|
|
|
2025-08-14 |
13G/A
|
CRGX / CARGO Therapeutics, Inc.
|
|
5,941,456 |
3,055,063 |
|
|
|
2025-08-14 |
13G/A
|
AXSM / Axsome Therapeutics, Inc.
|
|
2,922,729 |
1,516,903 |
|
|
|
2025-08-14 |
13G/A
|
AKRO / Akero Therapeutics, Inc.
|
|
6,859,823 |
5,873,308 |
|
|
|
2025-08-06 |
13D/A
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
8,306,063 |
8,306,063 |
|
|
|
2025-05-15 |
13G
|
TENX / Tenax Therapeutics, Inc.
|
|
|
418,440 |
|
|
|
2025-05-15 |
13G/A
|
ETNB / 89bio, Inc.
|
|
7,378,548 |
1,967,527 |
|
|
|
2025-05-15 |
13G/A
|
GHRS / GH Research PLC
|
|
3,327,129 |
5,499,769 |
|
|
|
2025-05-15 |
13G/A
|
PEPG / PepGen Inc.
|
|
3,193,097 |
0 |
|
|
|
2025-05-15 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
5,218,641 |
1,690,567 |
|
|
|
2025-05-15 |
13G
|
BBNX / Beta Bionics, Inc.
|
|
|
3,299,869 |
|
|
|
2025-05-15 |
13G/A
|
AXSM / Axsome Therapeutics, Inc.
|
|
4,051,365 |
2,922,729 |
|
|
|
2025-05-15 |
13G
|
VSTM / Verastem, Inc.
|
|
|
4,245,476 |
|
|
|
2025-05-15 |
13G
|
QURE / uniQure N.V.
|
|
|
4,265,428 |
|
|
|
2025-05-15 |
13G
|
RAPT / RAPT Therapeutics, Inc.
|
|
|
11,764,000 |
|
|
|
2025-05-15 |
13G
|
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
7,877,349 |
|
|
|
2025-05-15 |
13G
|
ORKA / Oruka Therapeutics, Inc.
|
|
|
1,945,649 |
|
|
|
2025-05-15 |
13G/A
|
IMUX / Immunic, Inc.
|
|
5,594,479 |
1,026,762 |
|
|
|
2025-05-15 |
13G/A
|
TSHA / Taysha Gene Therapies, Inc.
|
|
12,368,334 |
20,673,307 |
|
|
|
2025-05-01 |
13D/A
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
7,704,030 |
8,306,063 |
|
|
|
2025-04-17 |
13D/A
|
ALUR / Allurion Technologies Inc.
|
|
1,050,053 |
2,542,603 |
|
|
|
2025-02-24 |
13D/A
|
ALUR / Allurion Technologies Inc.
|
|
3,666,589 |
1,050,053 |
|
|
|
2025-02-14 |
13G/A
|
CUTRQ / Cutera, Inc.
|
|
1,817,585 |
0 |
|
|
|
2025-02-14 |
13G/A
|
GERN / Geron Corporation
|
|
44,111,916 |
0 |
|
|
|
2025-02-14 |
13G/A
|
AXSM / Axsome Therapeutics, Inc.
|
|
4,489,596 |
4,051,365 |
|
|
|
2025-02-14 |
13G/A
|
SYRE / Spyre Therapeutics, Inc.
|
|
2,232,760 |
3,621,996 |
|
|
|
2025-02-14 |
13G/A
|
SAGE / Sage Therapeutics, Inc.
|
|
5,197,019 |
3,002,370 |
|
|
|
2025-02-14 |
13G/A
|
IMTX / Immatics N.V.
|
|
10,000,000 |
6,540,540 |
|
|
|
2025-02-14 |
13G/A
|
TSHA / Taysha Gene Therapies, Inc.
|
|
18,505,556 |
12,368,334 |
|
|
|
2025-02-14 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
3,261,496 |
1,113,002 |
|
|
|
2025-02-14 |
13G
|
APGE / Apogee Therapeutics, Inc.
|
|
|
2,712,097 |
|
|
|
2025-02-14 |
13G/A
|
SABS / SAB Biotherapeutics, Inc.
|
|
9,220,672 |
1,024,335 |
|
|
|
2025-02-14 |
13G
|
PEPG / PepGen Inc.
|
|
|
3,193,097 |
|
|
|
2025-02-14 |
13G/A
|
NGNE / Neurogene Inc.
|
|
1,135,256 |
1,498,829 |
|
|
|
2025-02-14 |
13G/A
|
MIST / Milestone Pharmaceuticals Inc.
|
|
3,354,825 |
5,640,593 |
|
|
|
2025-02-14 |
13G/A
|
ESTA / Establishment Labs Holdings Inc.
|
|
2,494,138 |
2,822,216 |
|
|
|
2025-02-14 |
13G/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
13,707,506 |
8,705,501 |
|
|
|
2025-02-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
4,131,045 |
5,310,033 |
|
|
|
2025-02-14 |
13G/A
|
AKRO / Akero Therapeutics, Inc.
|
|
5,919,435 |
6,859,823 |
|
|
|
2025-02-14 |
13G/A
|
DYN / Dyne Therapeutics, Inc.
|
|
6,818,641 |
5,218,641 |
|
|
|
2025-01-29 |
13D/A
|
ALUR / Allurion Technologies Inc.
|
|
|
1,050,053 |
|
|
|
2025-01-16 |
13D/A
|
ALUR / Allurion Technologies Inc.
|
|
|
1,050,060 |
|
|
|
2025-01-10 |
13D/A
|
ALUR / Allurion Technologies Inc.
|
|
|
277,797 |
|
|
|
2024-12-16 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
18,188,457 |
|
|
|
|
2024-11-14 |
13G/A
|
ARVN / Arvinas, Inc.
|
|
4,213,483 |
2,782,329 |
|
|
|
2024-11-14 |
13G/A
|
IMUX / Immunic, Inc.
|
|
4,335,255 |
5,594,479 |
|
|
|
2024-11-14 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
2,298,662 |
3,261,496 |
|
|
|
2024-11-14 |
13G/A
|
CRGX / CARGO Therapeutics, Inc.
|
|
|
5,941,456 |
|
|
|
2024-11-14 |
13G/A
|
AKRO / Akero Therapeutics, Inc.
|
|
3,592,759 |
5,919,435 |
|
|
|
2024-11-14 |
13G/A
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
11,253,551 |
13,707,506 |
|
|
|
2024-11-14 |
13G/A
|
ETNB / 89bio, Inc.
|
|
5,578,931 |
7,378,548 |
|
|
|
2024-11-14 |
13G/A
|
URGN / UroGen Pharma Ltd.
|
|
1,726,808 |
4,930,204 |
|
|
|
2024-11-14 |
13G/A
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
6,887,086 |
1,968,002 |
|
|
|
2024-11-14 |
13G/A
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
6,096,387 |
4,869,798 |
|
|
|
2024-11-14 |
13G
|
PCSC / Perceptive Capital Solutions Corp
|
|
|
742,500 |
|
|
|
2024-11-14 |
13G
|
DYN / Dyne Therapeutics, Inc.
|
|
|
6,818,641 |
|
|
|
2024-11-14 |
13G
|
IMTX / Immatics N.V.
|
|
|
10,000,000 |
|
|
|
2024-11-14 |
13G
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
1,993,687 |
|
|
|
2024-11-14 |
13G
|
MRUS / Merus N.V.
|
|
|
4,169,393 |
|
|
|
2024-11-14 |
13G
|
GERN / Geron Corporation
|
|
|
44,111,916 |
|
|
|
2024-11-14 |
13G
|
NGNE / Neurogene Inc.
|
|
|
1,135,256 |
|
|
|
2024-11-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
3,212,794 |
0 |
|
|
|
2024-11-14 |
13G/A
|
PHAR / Pharming Group N.V. - Depositary Receipt (Common Stock)
|
|
38,496,391 |
0 |
|
|
|
2024-11-14 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
5,469,956 |
0 |
|
|
|
2024-11-14 |
13G/A
|
CLDX / Celldex Therapeutics, Inc.
|
|
3,463,201 |
0 |
|
|
|
2024-11-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
9,196,186 |
0 |
|
|
|
2024-11-14 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
4,134,631 |
0 |
|
|
|
2024-10-24 |
13D/A
|
ALUR / Allurion Technologies Inc.
|
|
4,416,587 |
3,666,589 |
|
|
|
2024-08-23 |
13D/A
|
RNA / Avidity Biosciences, Inc.
|
|
9,659,809 |
12,079,734 |
|
|
|
2024-08-07 |
13D/A
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
5,620,645 |
7,704,030 |
|
|
|
2024-07-02 |
13D/A
|
ALUR / Allurion Technologies Inc.
|
|
3,936,903 |
4,416,587 |
|
|
|
2024-04-17 |
13D/A
|
ALUR / Allurion Technologies Inc.
|
|
3,457,707 |
3,936,903 |
|
|
|
2024-03-01 |
13D/A
|
RNA / Avidity Biosciences, Inc.
|
|
6,701,489 |
9,659,809 |
|
|
|
2024-02-14 |
13G/A
|
MIST / Milestone Pharmaceuticals Inc.
|
|
4,315,102 |
3,354,825 |
|
|
|
2024-02-14 |
13G/A
|
XGN / Exagen Inc.
|
|
1,364,336 |
1,504,602 |
|
|
|
2024-02-14 |
13G/A
|
MRTX / Mirati Therapeutics, Inc.
|
|
3,643,114 |
0 |
|
|
|
2024-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
5,741,939 |
9,196,186 |
|
|
|
2024-02-14 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
5,615,387 |
7,423,970 |
|
|
|
2024-02-14 |
13G
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
11,253,551 |
|
|
|
2024-02-14 |
13G
|
SAGE / Sage Therapeutics, Inc.
|
|
|
5,197,019 |
|
|
|
2024-02-14 |
13G
|
SYRE / Spyre Therapeutics, Inc.
|
|
|
2,232,760 |
|
|
|
2024-02-14 |
13G
|
EPIX / ESSA Pharma Inc.
|
|
0 |
2,298,662 |
|
|
|
2024-02-14 |
13G
|
ARVN / Arvinas, Inc.
|
|
|
4,213,483 |
|
|
|
2024-02-14 |
13G
|
AKRO / Akero Therapeutics, Inc.
|
|
|
3,592,759 |
|
|
|
2024-02-14 |
13G
|
URGN / UroGen Pharma Ltd.
|
|
|
1,726,808 |
|
|
|
2024-02-14 |
13G
|
ETNB / 89bio, Inc.
|
|
|
5,578,931 |
|
|
|
2024-02-14 |
13G
|
PHAR / Pharming Group N.V. - Depositary Receipt (Common Stock)
|
|
|
38,496,391 |
|
|
|
2024-02-14 |
13G
|
SABS / SAB Biotherapeutics, Inc.
|
|
|
9,220,672 |
|
|
|
2024-02-14 |
13G
|
GHRS / GH Research PLC
|
|
|
3,327,129 |
|
|
|
2024-02-14 |
13G
|
TSHA / Taysha Gene Therapies, Inc.
|
|
|
18,505,556 |
|
|
|
2024-02-14 |
13G/A
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
5,559,322 |
6,096,387 |
|
|
|
2024-02-14 |
13G/A
|
IMUX / Immunic, Inc.
|
|
3,861,290 |
4,335,255 |
|
|
|
2024-02-14 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
4,993,279 |
5,469,956 |
|
|
|
2024-02-14 |
13G/A
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
4,356,920 |
0 |
|
|
|
2024-02-14 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
2,067,824 |
0 |
|
|
|
2024-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
3,591,986 |
5,315,514 |
|
|
|
2024-02-14 |
13G/A
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
3,966,915 |
6,887,086 |
|
|
|
2024-02-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
3,870,981 |
4,131,045 |
|
|
|
2024-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
3,099,904 |
3,212,794 |
|
|
|
2024-02-14 |
13G/A
|
ESTA / Establishment Labs Holdings Inc.
|
|
2,374,138 |
2,494,138 |
|
|
|
2024-02-14 |
13G/A
|
CLDX / Celldex Therapeutics, Inc.
|
|
3,084,215 |
3,463,201 |
|
|
|
2024-02-14 |
13G/A
|
CCCC / C4 Therapeutics, Inc.
|
|
2,819,472 |
0 |
|
|
|
2024-02-14 |
13G/A
|
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
|
|
3,204,762 |
0 |
|
|
|
2024-02-14 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
3,398,279 |
1,025,963 |
|
|
|
2024-02-14 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
4,241,472 |
4,134,631 |
|
|
|
2024-02-14 |
13G/A
|
TNYA / Tenaya Therapeutics, Inc.
|
|
2,458,750 |
0 |
|
|
|
2024-02-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
2,548,125 |
3,152,341 |
|
|
|
2024-02-14 |
13G/A
|
AXSM / Axsome Therapeutics, Inc.
|
|
2,980,482 |
4,489,596 |
|
|
|
2024-01-24 |
13D/A
|
RNA / Avidity Biosciences, Inc.
|
|
5,956,558 |
6,701,489 |
|
|
|
2024-01-19 |
13G
|
CUTRQ / Cutera, Inc.
|
|
1,846,596 |
1,817,585 |
|
|
|
2023-12-12 |
13D/A
|
DMTKQ / DermTech, Inc.
|
|
3,018,666 |
0 |
|
|
|
2023-11-24 |
13G
|
LYRA / Lyra Therapeutics, Inc.
|
|
|
5,175,832 |
|
|
|
2023-09-19 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
18,188,457 |
18,188,457 |
|
|
|
2023-08-11 |
13D
|
ALUR / Allurion Technologies Inc.
|
|
|
3,457,707 |
|
|
|
2023-05-10 |
13D/A
|
CUTRQ / Cutera, Inc.
|
|
1,846,596 |
1,846,596 |
|
|
|
2023-05-05 |
13D/A
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
5,118,512 |
5,620,645 |
|
|
|
2023-04-13 |
13D
|
CUTRQ / Cutera, Inc.
|
|
1,798,675 |
1,846,596 |
|
|
|
2023-04-05 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
17,628,567 |
18,188,457 |
|
|
|
2023-04-05 |
13D/A
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
3,350,803 |
0 |
|
|
|
2023-02-14 |
13G/A
|
CLSD / Clearside Biomedical, Inc.
|
|
3,806,018 |
0 |
|
|
|
2023-02-14 |
13G/A
|
ATHA / Athira Pharma, Inc.
|
|
1,906,557 |
0 |
|
|
|
2023-02-14 |
13G/A
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
16,250,000 |
0 |
|
|
|
2023-02-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
6,029,700 |
0 |
|
|
|
2023-02-14 |
13G/A
|
ADVM / Adverum Biotechnologies, Inc.
|
|
7,554,817 |
0 |
|
|
|
2023-02-14 |
13G/A
|
BLU / Bellus Health Inc
|
|
5,968,017 |
0 |
|
|
|
2023-02-14 |
13G/A
|
APVO / Aptevo Therapeutics Inc.
|
|
288,236 |
0 |
|
|
|
2023-02-14 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
7,027,725 |
0 |
|
|
|
2023-02-14 |
13G/A
|
MGNX / MacroGenics, Inc.
|
|
3,975,554 |
0 |
|
|
|
2023-02-14 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
2,186,324 |
2,067,824 |
|
|
|
2023-02-14 |
13G/A
|
TELA / TELA Bio, Inc.
|
|
1,399,686 |
390,364 |
|
|
|
2023-02-14 |
13G
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
3,966,915 |
|
|
|
2023-02-14 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
2,520,076 |
0 |
|
|
|
2023-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
4,517,570 |
3,099,904 |
|
|
|
2023-02-14 |
13G/A
|
CLDX / Celldex Therapeutics, Inc.
|
|
3,921,579 |
3,084,215 |
|
|
|
2023-02-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
2,013,601 |
2,548,125 |
|
|
|
2023-02-14 |
13G
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
3,643,114 |
|
|
|
2023-02-14 |
13G/A
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
2,980,960 |
4,356,920 |
|
|
|
2023-02-14 |
13G
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
2,980,482 |
|
|
|
2023-02-14 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
2,353,015 |
0 |
|
|
|
2023-02-14 |
13G/A
|
CCCC / C4 Therapeutics, Inc.
|
|
2,494,965 |
2,819,472 |
|
|
|
2023-02-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
3,644,248 |
3,870,981 |
|
|
|
2023-02-14 |
13G/A
|
RXDX / Prometheus Biosciences Inc
|
|
|
3,354,303 |
|
|
|
2023-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
2,590,932 |
0 |
|
|
|
2023-02-14 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
6,722,624 |
821,288 |
|
|
|
2023-02-14 |
13G/A
|
IMUX / Immunic, Inc.
|
|
1,715,470 |
3,861,290 |
|
|
|
2023-02-14 |
13G/A
|
JNCE / Jounce Therapeutics Inc
|
|
2,863,198 |
5,106,341 |
|
|
|
2023-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
2,599,822 |
3,591,986 |
|
|
|
2023-02-14 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
2,637,192 |
0 |
|
|
|
2023-02-14 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
3,866,872 |
4,993,279 |
|
|
|
2023-02-14 |
13G
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
5,559,322 |
|
|
|
2023-02-14 |
13G/A
|
OYST / Oyster Point Pharma Inc
|
|
2,058,504 |
2,304,977 |
|
|
|
2023-02-14 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
5,293,966 |
5,615,387 |
|
|
|
2023-02-14 |
13G/A
|
CUTR / Cutera, Inc.
|
|
1,397,063 |
1,798,675 |
|
|
|
2023-02-14 |
13G/A
|
ESTA / Establishment Labs Holdings Inc.
|
|
2,319,138 |
2,374,138 |
|
|
|
2023-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
5,810,140 |
5,741,939 |
|
|
|
2023-02-14 |
13G/A
|
PYXS / Pyxis Oncology, Inc.
|
|
2,120,760 |
0 |
|
|
|
2023-02-14 |
13G/A
|
XGN / Exagen Inc.
|
|
821,414 |
1,364,336 |
|
|
|
2023-02-14 |
13G/A
|
ACET / Adicet Bio, Inc.
|
|
3,023,744 |
4,241,472 |
|
|
|
2023-02-02 |
13D/A
|
RNA / Avidity Biosciences, Inc.
|
|
3,995,000 |
5,956,558 |
|
|
|
2023-01-27 |
13D/A
|
OBIO / Orchestra BioMed Holdings, Inc.
|
|
1,000,000 |
5,118,512 |
|
|
|
2022-12-05 |
13G/A
|
IMVT / Immunovant, Inc.
|
|
8,459,241 |
0 |
|
|
|
2022-12-02 |
13G/A
|
IMVT / Immunovant, Inc.
|
|
7,592,253 |
8,459,241 |
|
|
|
2022-11-08 |
13D/A
|
DMTK / DermTech, Inc.
|
|
3,118,666 |
3,018,666 |
|
|
|
2022-11-03 |
13D/A
|
LABP / Landos Biopharma, Inc.
|
|
3,150,722 |
0 |
|
|
|
2022-10-31 |
13D/A
|
LABP / Landos Biopharma, Inc.
|
|
3,650,722 |
3,150,722 |
|
|
|
2022-10-12 |
13D
|
HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
1,000,000 |
|
|
|
2022-10-11 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
16,272,635 |
17,628,567 |
|
|
|
2022-10-06 |
13D/A
|
LABP / Landos Biopharma, Inc.
|
|
4,275,722 |
3,650,722 |
|
|
|
2022-09-21 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
16,272,635 |
16,272,635 |
|
|
|
2022-09-21 |
13D
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
2,997,540 |
3,350,803 |
|
|
|
2022-02-14 |
13G/A
|
ABUS / Arbutus Biopharma Corporation
|
|
5,978,355 |
2,504,493 |
|
|
|
2022-02-14 |
13G/A
|
AGEN / Agenus Inc.
|
|
12,864,677 |
5,868,315 |
|
|
|
2022-02-14 |
13G/A
|
LSAQ / LifeSci Acquisition II Corp
|
|
975,000 |
3,975,000 |
|
|
|
2022-02-14 |
13G/A
|
VINC / Vincerx Pharma, Inc.
|
|
750,000 |
741,236 |
|
|
|
2022-02-14 |
13G
|
CCCC / C4 Therapeutics, Inc.
|
|
|
2,494,965 |
|
|
|
2022-02-14 |
13G
|
TNYA / Tenaya Therapeutics, Inc.
|
|
|
2,458,750 |
|
|
|
2022-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
2,397,378 |
2,590,932 |
|
|
|
2022-02-14 |
13G/A
|
CTMX / CytomX Therapeutics, Inc.
|
|
5,868,326 |
6,029,700 |
|
|
|
2022-02-14 |
13G/A
|
XGN / Exagen Inc.
|
|
1,250,131 |
821,414 |
|
|
|
2022-02-14 |
13G
|
JNCE / Jounce Therapeutics Inc
|
|
|
2,863,198 |
|
|
|
2022-02-14 |
13G
|
ASLN / ASLAN Pharmaceuticals Limited - Depositary Receipt (Common Stock)
|
|
|
16,250,000 |
|
|
|
2022-02-14 |
13G
|
PYXS / Pyxis Oncology, Inc.
|
|
|
2,120,760 |
|
|
|
2022-02-14 |
13G
|
MGNX / MacroGenics, Inc.
|
|
|
3,975,554 |
|
|
|
2022-02-14 |
13G/A
|
ADVM / Adverum Biotechnologies, Inc.
|
|
7,227,364 |
7,554,817 |
|
|
|
2022-02-14 |
13G/A
|
EPIX / ESSA Pharma Inc.
|
|
3,028,719 |
2,637,192 |
|
|
|
2022-02-14 |
13G/A
|
CUTR / Cutera, Inc.
|
|
1,375,663 |
1,397,063 |
|
|
|
2022-02-14 |
13G/A
|
OYST / Oyster Point Pharma Inc
|
|
1,925,594 |
2,058,504 |
|
|
|
2022-02-14 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
1,512,673 |
2,186,324 |
|
|
|
2022-02-14 |
13G/A
|
CLSD / Clearside Biomedical, Inc.
|
|
3,958,130 |
3,806,018 |
|
|
|
2022-02-14 |
13G/A
|
IDYA / IDEAYA Biosciences, Inc.
|
|
2,096,843 |
2,520,076 |
|
|
|
2022-02-14 |
13G/A
|
CLDX / Celldex Therapeutics, Inc.
|
|
3,422,855 |
3,921,579 |
|
|
|
2022-02-14 |
13G/A
|
ITOS / iTeos Therapeutics, Inc.
|
|
2,762,791 |
2,353,015 |
|
|
|
2022-02-14 |
13G
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
|
2,980,960 |
|
|
|
2022-02-14 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
2,071,409 |
3,866,872 |
|
|
|
2022-02-14 |
13G/A
|
TELA / TELA Bio, Inc.
|
|
1,383,816 |
1,399,686 |
|
|
|
2022-02-14 |
13G/A
|
ESTA / Establishment Labs Holdings Inc.
|
|
2,319,138 |
2,319,138 |
|
|
|
2022-02-14 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
2,463,601 |
2,013,601 |
|
|
|
2022-02-14 |
13G/A
|
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
|
|
2,206,948 |
3,204,762 |
|
|
|
2022-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
5,387,513 |
5,810,140 |
|
|
|
2022-02-14 |
13G
|
IMUX / Immunic, Inc.
|
|
|
1,715,470 |
|
|
|
2022-02-14 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
5,088,493 |
7,027,725 |
|
|
|
2022-02-14 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
3,391,279 |
3,398,279 |
|
|
|
2022-02-14 |
13G/A
|
ATHA / Athira Pharma, Inc.
|
|
2,685,779 |
1,906,557 |
|
|
|
2022-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
3,650,069 |
2,599,822 |
|
|
|
2022-02-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
3,544,248 |
3,644,248 |
|
|
|
2022-02-14 |
13G/A
|
BLU / Bellus Health Inc
|
|
5,189,862 |
5,968,017 |
|
|
|
2022-02-14 |
13G/A
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
2,362,540 |
2,997,540 |
|
|
|
2022-02-14 |
13G/A
|
MIST / Milestone Pharmaceuticals Inc.
|
|
4,315,201 |
4,315,102 |
|
|
|
2022-02-14 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
4,968,209 |
5,293,966 |
|
|
|
2021-12-15 |
13G
|
ACET / Adicet Bio, Inc.
|
|
|
3,023,744 |
|
|
|
2021-12-08 |
13G
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
5,868,326 |
|
|
|
2021-11-03 |
13G
|
CUTR / Cutera, Inc.
|
|
|
1,375,663 |
|
|
|
2021-09-07 |
13G/A
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
1,387,540 |
2,362,540 |
|
|
|
2021-08-31 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
16,185,119 |
16,272,635 |
|
|
|
2021-07-29 |
13G
|
CHAQ / Chardan Healthcare Acquisition 2 Corp
|
|
|
1,387,540 |
|
|
|
2021-07-02 |
13G
|
EPIX / ESSA Pharma Inc.
|
|
|
3,028,719 |
|
|
|
2021-05-18 |
13G
|
LSAQ / LifeSci Acquisition II Corp
|
|
650,000 |
975,000 |
|
|
|
2021-04-06 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
5,088,493 |
5,088,493 |
|
|
|
2021-04-06 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
5,009,768 |
5,088,493 |
|
|
|
2021-03-29 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
17,530,044 |
16,185,119 |
|
|
|
2021-02-26 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
4,221,836 |
4,968,209 |
|
|
|
2021-02-16 |
13D
|
LABP / Landos Biopharma, Inc.
|
|
|
4,275,722 |
|
|
|
2021-02-16 |
13G/A
|
IMVT / Immunovant, Inc.
|
|
|
7,592,253 |
|
|
|
2021-02-16 |
13G
|
HLXA / Helix Acquisition Corp - Class A
|
|
|
750,000 |
|
|
|
2021-02-16 |
13G
|
FREQ / Frequency Therapeutics Inc
|
|
|
2,461,486 |
|
|
|
2021-02-16 |
13G
|
VINC / Vincerx Pharma, Inc.
|
|
|
750,000 |
|
|
|
2021-02-16 |
13G
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
650,000 |
|
|
|
2021-02-16 |
13G
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
2,515,788 |
|
|
|
2021-02-12 |
13G/A
|
ISEE / IVERIC bio Inc
|
|
6,121,882 |
6,722,624 |
|
|
|
2021-02-12 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
3,832,480 |
4,221,836 |
|
|
|
2021-02-12 |
13G/A
|
ADVM / Adverum Biotechnologies, Inc.
|
|
6,386,607 |
7,227,364 |
|
|
|
2021-02-12 |
13G/A
|
FULC / Fulcrum Therapeutics, Inc.
|
|
2,071,409 |
2,071,409 |
|
|
|
2021-02-12 |
13G/A
|
FIXX / Homology Medicines, Inc.
|
|
4,349,250 |
0 |
|
|
|
2021-02-12 |
13G/A
|
ESTA / Establishment Labs Holdings Inc.
|
|
2,032,446 |
2,319,138 |
|
|
|
2021-02-12 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
5,874,229 |
7,253,857 |
|
|
|
2021-02-12 |
13G/A
|
COGT / Cogent Biosciences, Inc.
|
|
1,258,750 |
1,998,750 |
|
|
|
2021-02-12 |
13G/A
|
CLSD / Clearside Biomedical, Inc.
|
|
3,750,107 |
3,958,130 |
|
|
|
2021-02-12 |
13G/A
|
CLDX / Celldex Therapeutics, Inc.
|
|
1,885,000 |
3,422,855 |
|
|
|
2021-02-12 |
13G/A
|
XGN / Exagen Inc.
|
|
902,085 |
1,250,131 |
|
|
|
2021-02-12 |
13G/A
|
WVE / Wave Life Sciences Ltd.
|
|
2,414,027 |
0 |
|
|
|
2021-02-12 |
13G/A
|
VCEL / Vericel Corporation
|
|
2,989,429 |
4,517,570 |
|
|
|
2021-02-12 |
13G/A
|
TELA / TELA Bio, Inc.
|
|
1,139,358 |
1,383,816 |
|
|
|
2021-02-12 |
13G/A
|
TBIO / Telesis Bio, Inc.
|
|
3,304,808 |
2,978,427 |
|
|
|
2021-02-12 |
13G/A
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
2,463,601 |
2,463,601 |
|
|
|
2021-02-12 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
3,544,248 |
3,544,248 |
|
|
|
2021-02-12 |
13G/A
|
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
|
|
1,916,852 |
2,206,948 |
|
|
|
2021-02-12 |
13G/A
|
RLMD / Relmada Therapeutics, Inc.
|
|
1,255,857 |
1,512,673 |
|
|
|
2021-02-12 |
13G/A
|
BLU / Bellus Health Inc
|
|
4,840,992 |
5,189,862 |
|
|
|
2021-02-12 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
2,459,988 |
3,650,069 |
|
|
|
2021-02-12 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
3,401,434 |
5,387,513 |
|
|
|
2021-02-12 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
4,779,135 |
5,009,768 |
|
|
|
2021-02-12 |
13G/A
|
ATHA / Athira Pharma, Inc.
|
|
2,668,913 |
2,685,779 |
|
|
|
2021-02-12 |
13G/A
|
OYST / Oyster Point Pharma Inc
|
|
1,914,606 |
1,925,594 |
|
|
|
2021-02-12 |
13G/A
|
MIST / Milestone Pharmaceuticals Inc.
|
|
3,958,264 |
4,315,201 |
|
|
|
2021-02-12 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
3,391,279 |
3,391,279 |
|
|
|
2021-02-12 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
2,551,020 |
2,397,378 |
|
|
|
2021-02-12 |
13G/A
|
APVO / Aptevo Therapeutics Inc.
|
|
290,000 |
288,236 |
|
|
|
2021-02-12 |
13G/A
|
ABUS / Arbutus Biopharma Corporation
|
|
5,666,754 |
5,978,355 |
|
|
|
2021-02-12 |
13G/A
|
AGEN / Agenus Inc.
|
|
13,725,251 |
12,864,677 |
|
|
|
2021-02-04 |
13G
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
2,762,791 |
|
|
|
2021-01-22 |
13G
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
2,096,843 |
|
|
|
2021-01-19 |
13D/A
|
DMTK / DermTech, Inc.
|
|
2,658,627 |
3,118,666 |
|
|
|
2021-01-08 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
17,282,324 |
17,530,044 |
|
|
|
2020-12-03 |
13G
|
COGT / Cogent Biosciences, Inc.
|
|
|
1,258,750 |
|
|
|
2020-11-16 |
13G
|
APVO / Aptevo Therapeutics Inc.
|
|
|
290,000 |
|
|
|
2020-11-13 |
13G
|
FULC / Fulcrum Therapeutics, Inc.
|
|
|
2,071,409 |
|
|
|
2020-10-26 |
13G
|
TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
2,463,601 |
|
|
|
2020-09-28 |
13G
|
ATHA / Athira Pharma, Inc.
|
|
|
2,668,913 |
|
|
|
2020-06-29 |
13G
|
ISEE / IVERIC bio Inc
|
|
|
6,121,882 |
|
|
|
2020-06-22 |
13D
|
RNA / Avidity Biosciences, Inc.
|
|
|
3,995,000 |
|
|
|
2020-06-19 |
13G
|
CLDX / Celldex Therapeutics, Inc.
|
|
|
1,885,000 |
|
|
|
2020-06-11 |
13G
|
RLMD / Relmada Therapeutics, Inc.
|
|
|
1,255,857 |
|
|
|
2020-05-22 |
13G
|
OYST / Oyster Point Pharma Inc
|
|
|
1,914,606 |
|
|
|
2020-03-09 |
13D/A
|
DMTK / DermTech, Inc.
|
|
2,449,769 |
2,658,627 |
|
|
|
2020-02-26 |
13G/A
|
PHGE / BiomX Inc.
|
|
900,000 |
900,000 |
|
|
|
2020-02-14 |
13G/A
|
CNCE / Concert Pharmaceuticals Inc
|
|
1,811,662 |
0 |
|
|
|
2020-02-14 |
13G/A
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
6,916,079 |
0 |
|
|
|
2020-02-14 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
5,907,088 |
5,874,229 |
|
|
|
2020-02-14 |
13G/A
|
AGEN / Agenus Inc.
|
|
14,984,569 |
13,725,251 |
|
|
|
2020-02-14 |
13G/A
|
ABUS / Arbutus Biopharma Corporation
|
|
4,335,746 |
5,666,754 |
|
|
|
2020-02-14 |
13G/A
|
MIST / Milestone Pharmaceuticals Inc.
|
|
3,521,856 |
3,958,264 |
|
|
|
2020-02-14 |
13G/A
|
AVDL / Avadel Pharmaceuticals plc
|
|
3,396,155 |
3,401,434 |
|
|
|
2020-02-14 |
13G/A
|
BLU / Bellus Health Inc
|
|
|
4,840,992 |
|
|
|
2020-02-14 |
13G/A
|
ADVM / Adverum Biotechnologies, Inc.
|
|
6,256,840 |
6,386,607 |
|
|
|
2020-02-14 |
13G/A
|
TELA / TELA Bio, Inc.
|
|
1,151,458 |
1,139,358 |
|
|
|
2020-02-14 |
13G/A
|
AXNX / Axonics, Inc.
|
|
1,418,510 |
1,591,632 |
|
|
|
2020-02-14 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
3,569,613 |
4,779,135 |
|
|
|
2020-02-14 |
13G/A
|
STOK / Stoke Therapeutics, Inc.
|
|
3,355,466 |
3,544,248 |
|
|
|
2020-02-14 |
13G/A
|
FIXX / Homology Medicines, Inc.
|
|
3,883,143 |
4,349,250 |
|
|
|
2020-02-14 |
13G/A
|
ESTA / Establishment Labs Holdings Inc.
|
|
1,054,091 |
2,032,446 |
|
|
|
2020-02-14 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
2,391,898 |
3,391,279 |
|
|
|
2020-02-14 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
5,316,156 |
0 |
|
|
|
2020-02-14 |
13G/A
|
VIVE / Viveve Medical, Inc.
|
|
4,480,565 |
0 |
|
|
|
2020-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
2,289,134 |
2,989,429 |
|
|
|
2020-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
2,274,369 |
2,551,020 |
|
|
|
2020-02-14 |
13G
|
PTCT / PTC Therapeutics, Inc.
|
|
1,922,346 |
3,832,480 |
|
|
|
2020-02-14 |
13G
|
TBIO / Telesis Bio, Inc.
|
|
|
3,304,808 |
|
|
|
2020-02-14 |
13G/A
|
PTGX / Protagonist Therapeutics, Inc.
|
|
2,186,657 |
2,459,988 |
|
|
|
2020-02-14 |
13G/A
|
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
|
|
|
1,916,852 |
|
|
|
2020-02-14 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
13,749,383 |
7,309,383 |
|
|
|
2020-02-14 |
13G/A
|
SIBN / SI-BONE, Inc.
|
|
1,234,118 |
0 |
|
|
|
2020-02-14 |
13G/A
|
CLSD / Clearside Biomedical, Inc.
|
|
3,747,699 |
3,750,107 |
|
|
|
2020-02-14 |
13G/A
|
PHGE / BiomX Inc.
|
|
|
900,000 |
|
|
|
2020-01-27 |
13G
|
XGN / Exagen Inc.
|
|
|
902,085 |
|
|
|
2020-01-21 |
13G
|
WVE / Wave Life Sciences Ltd.
|
|
|
2,414,027 |
|
|
|
2019-12-30 |
13G
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
3,396,155 |
|
|
|
2019-12-30 |
13G
|
FIXX / Homology Medicines, Inc.
|
|
|
3,883,143 |
|
|
|
2019-12-17 |
13G/A
|
TELA / TELA Bio, Inc.
|
|
894,231 |
1,151,458 |
|
|
|
2019-12-16 |
13G
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
2,186,657 |
|
|
|
2019-12-13 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
17,057,324 |
17,282,324 |
|
|
|
2019-11-18 |
13G
|
TELA / TELA Bio, Inc.
|
|
|
894,231 |
|
|
|
2019-09-23 |
13G
|
CLSD / Clearside Biomedical, Inc.
|
|
|
3,747,699 |
|
|
|
2019-09-16 |
13G
|
BLUSF / BELLUS Health Inc.
|
|
|
3,618,343 |
|
|
|
2019-09-09 |
13D
|
DMTK / DermTech, Inc.
|
|
|
2,449,769 |
|
|
|
2019-09-09 |
13D
|
CNAC / Constellation Alpha Capital Corp.
|
|
|
2,449,769 |
|
|
|
2019-08-19 |
13G
|
BRSYF / BrainsWay Ltd.
|
|
|
1,453,218 |
|
|
|
2019-07-22 |
13G
|
867328601 / Sunesis Pharmaceuticals, Inc.
|
|
|
6,916,079 |
|
|
|
2019-06-28 |
13G
|
STOK / Stoke Therapeutics, Inc.
|
|
|
3,355,466 |
|
|
|
2019-06-14 |
13G
|
LJPC / La Jolla Pharmaceutical Co.
|
|
531,065 |
2,274,369 |
|
|
|
2019-05-20 |
13G
|
MIST / Milestone Pharmaceuticals Inc.
|
|
|
3,521,856 |
|
|
|
2019-04-18 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
16,407,319 |
17,057,324 |
|
|
|
2019-03-25 |
13G
|
CNCE / Concert Pharmaceuticals Inc
|
|
|
1,811,662 |
|
|
|
2019-02-22 |
13G
|
PRQR / ProQR Therapeutics N.V.
|
|
448,141 |
3,569,613 |
|
|
|
2019-02-15 |
13G
|
SIBN / SI-BONE, Inc.
|
|
|
1,234,118 |
|
|
|
2019-02-14 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
|
2,391,898 |
|
|
|
2019-02-14 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
13,546,902 |
13,749,383 |
|
|
|
2019-02-14 |
13G/A
|
ADVM / Adverum Biotechnologies, Inc.
|
|
3,841,226 |
6,256,840 |
|
|
|
2019-02-14 |
13G/A
|
AGEN / Agenus Inc.
|
|
5,009,949 |
14,984,569 |
|
|
|
2019-02-14 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
1,752,611 |
2,391,898 |
|
|
|
2019-02-14 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
363,597 |
0 |
|
|
|
2019-02-14 |
13G/A
|
ABUS / Arbutus Biopharma Corporation
|
|
5,151,615 |
4,335,746 |
|
|
|
2019-02-14 |
13G/A
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
4,358,067 |
5,316,156 |
|
|
|
2019-02-14 |
13G/A
|
CHAC.WS / Chardan Healthcare Acquisition Corp.
|
|
600,000 |
600,000 |
|
|
|
2019-02-14 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
5,035,662 |
5,907,088 |
|
|
|
2019-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,326,199 |
531,065 |
|
|
|
2019-02-14 |
13G/A
|
NVTR / Nuvectra Corporation
|
|
737,619 |
0 |
|
|
|
2019-02-14 |
13G/A
|
VCEL / Vericel Corporation
|
|
1,758,914 |
2,289,134 |
|
|
|
2019-02-14 |
13G/A
|
PRQR / ProQR Therapeutics N.V.
|
|
1,903,158 |
448,141 |
|
|
|
2019-02-14 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
4,130,115 |
1,922,346 |
|
|
|
2019-02-14 |
13G/A
|
RGNX / REGENXBIO Inc.
|
|
1,561,210 |
1,050,245 |
|
|
|
2019-02-14 |
13G/A
|
VIVE / Viveve Medical, Inc.
|
|
1,672,998 |
4,480,565 |
|
|
|
2019-01-28 |
13G
|
AXNX / Axonics, Inc.
|
|
|
1,418,510 |
|
|
|
2019-01-18 |
13G
|
ESTA / Establishment Labs Holdings Inc.
|
|
|
1,054,091 |
|
|
|
2018-12-21 |
13G
|
CHAC.WS / Chardan Healthcare Acquisition Corp.
|
|
|
600,000 |
|
|
|
2018-11-29 |
13D/A
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
16,407,319 |
|
|
|
2018-11-16 |
13G
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
3,841,226 |
|
|
|
2018-09-17 |
13G
|
PRQR / ProQR Therapeutics N.V.
|
|
|
1,903,158 |
|
|
|
2018-05-14 |
13G
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
4,358,067 |
|
|
|
2018-05-14 |
13G
|
NVTR / Nuvectra Corporation
|
|
|
737,619 |
|
|
|
2018-03-05 |
13G
|
CORI / Corium International, Inc.
|
|
1,699,653 |
1,910,522 |
|
|
|
2018-02-14 |
13G/A
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
7,096,936 |
13,546,902 |
|
|
|
2018-02-14 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
2,043,216 |
5,035,662 |
|
|
|
2018-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,349,066 |
1,326,199 |
|
|
|
2018-02-14 |
13G/A
|
ABUS / Arbutus Biopharma Corporation
|
|
2,770,284 |
5,151,615 |
|
|
|
2018-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
4,078,895 |
3,372,674 |
|
|
|
2018-02-14 |
13G/A
|
VIVE / Viveve Medical, Inc.
|
|
839,666 |
1,672,998 |
|
|
|
2018-02-14 |
13G/A
|
RGNX / REGENXBIO Inc.
|
|
1,547,885 |
1,561,210 |
|
|
|
2018-02-14 |
13G/A
|
APYX / Apyx Medical Corporation
|
|
1,682,611 |
1,752,611 |
|
|
|
2018-02-14 |
13G/A
|
PTCT / PTC Therapeutics, Inc.
|
|
1,794,336 |
4,130,115 |
|
|
|
2018-02-14 |
13G/A
|
CORI / Corium International, Inc.
|
|
1,461,447 |
1,699,653 |
|
|
|
2018-02-12 |
13G
|
AGEN / Agenus Inc.
|
|
|
5,009,949 |
|
|
|
2018-02-05 |
13G
|
CBIO / Crescent Biopharma, Inc.
|
|
313,264 |
363,597 |
|
|
|
2018-01-18 |
13G
|
VCEL / Vericel Corporation
|
|
|
1,758,914 |
|
|
|
2018-01-16 |
13D
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
15,439,557 |
|
|
|
2018-01-16 |
13D
|
RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
15,439,557 |
|
|
|
2018-01-09 |
13G
|
APYX / Apyx Medical Corporation
|
|
|
1,682,611 |
|
|
|
2017-10-05 |
13G
|
RGNX / REGENXBIO Inc.
|
|
|
1,547,885 |
|
|
|
2017-09-28 |
13G
|
US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
7,096,936 |
|
|
|
2017-05-17 |
13G
|
ABUS / Arbutus Biopharma Corporation
|
|
|
2,770,284 |
|
|
|
2017-05-05 |
13G
|
CORI / Corium International, Inc.
|
|
|
1,461,447 |
|
|
|
2017-04-21 |
13G
|
PTCT / PTC Therapeutics, Inc.
|
|
|
1,794,336 |
|
|
|
2017-02-15 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
2,012,662 |
2,043,216 |
|
|
|
2017-02-15 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
3,701,460 |
4,078,895 |
|
|
|
2017-02-15 |
13G/A
|
VIVE / Viveve Medical, Inc.
|
|
4,753,806 |
839,666 |
|
|
|
2017-02-15 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
1,347,445 |
1,349,066 |
|
|
|
2016-08-26 |
13G
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
3,701,460 |
|
|
|
2016-08-03 |
13G
|
SRTS / Sensus Healthcare, Inc.
|
|
155,000 |
310,000 |
|
|
|
2016-07-14 |
13G/A
|
SSRG / Symmetry Surgical Inc.
|
|
879,623 |
0 |
|
|
|
2016-06-13 |
13G
|
SRTS / Sensus Healthcare, Inc.
|
|
|
155,000 |
|
|
|
2016-02-11 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
1,347,445 |
|
|
|
2016-02-09 |
13G/A
|
VIVE / Viveve Medical, Inc.
|
|
3,591,378 |
4,753,806 |
|
|
|
2016-02-09 |
13G/A
|
SSRG / Symmetry Surgical Inc.
|
|
523,205 |
879,623 |
|
|
|
2016-02-09 |
13G/A
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
2,012,662 |
|
|
|
2016-02-09 |
13G/A
|
CBIO / Crescent Biopharma, Inc.
|
|
0 |
313,264 |
|
|
|
2015-10-02 |
13G
|
VIVE / Viveve Medical, Inc.
|
|
|
3,591,378 |
|
|
|
2015-06-03 |
13G
|
SSRG / Symmetry Surgical Inc.
|
|
|
523,205 |
|
|
|
2015-02-17 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
1,327,261 |
|
|
|
2015-02-17 |
13G/A
|
TRGT / Targacept
|
|
|
2,665,643 |
|
|
|
2014-12-29 |
13G
|
DRNA / Dicerna Pharmaceuticals Inc
|
|
|
1,115,981 |
|
|
|
2014-10-03 |
13G/A
|
PHIO / Phio Pharmaceuticals Corp.
|
|
|
0 |
|
|
|
2014-06-11 |
13G
|
TRGT / Targacept
|
|
|
1,930,407 |
|
|
|
2014-05-28 |
13G
|
CHTP / Chelsea Therapeutics International, Ltd.
|
|
|
4,299,722 |
|
|
|
2014-02-14 |
13G/A
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
2,460,865 |
|
|
|
2014-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
19,184,048 |
|
|
|
2013-08-02 |
13G
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
2,728,709 |
|
|
|
2013-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
1,489,878 |
|
|
|
2013-01-18 |
13G
|
SOMX / Somaxon Pharmaceuticals, Inc.
|
|
|
389,098 |
|
|
|
2012-07-09 |
13G
|
PHIO / Phio Pharmaceuticals Corp.
|
|
|
14,186,638 |
|
|
|
2012-02-16 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
8,791,667 |
|
|
|
2012-02-14 |
13G/A
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
0 |
|
|
|